Archer Materials Advances Biochip Technology

Archer Materials Limited (AU:AXE) has released an update.

Archer Materials Limited, a semiconductor company focused on quantum technology and medical diagnostics, has successfully fabricated its advanced Biochip graphene field effect transistor (gFET) design on a six-inch wafer, a first for the company and a step between research and commercial-scale production. The fabrication, done through Spanish partner Graphenea, produced 145 chips, each with 8 gFET devices, and showed the expected electronic performance and device stability. This milestone is part of Archer’s ongoing efforts to refine its Biochip technology, with further miniaturized designs currently in fabrication.

For further insights into AU:AXE stock, check out TipRanks’ Stock Analysis page.

TipRanks
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available